SEC Form D private-offering filing
AB Science S.A.
A new SEC Form D private-offering notice from Paris, a $2,016,160 filer-stated offering target in Biotech. The source filing is one click away.
AB Science is a publicly traded, France based clinical stage biopharmaceutical company developing targeted therapies, including tyrosine kinase inhibitors, for cancers, chronic inflammatory diseases and neurodegenerative disorders.
Filed 5 days agoFiled to raise $2,016,160First money in 2026-07-03Raised so far $2,016,160HQ (as filed) ParisSector Biotech ✓Stage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified ab-science.com↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.